Table 2 Patient characteristics stratified by magnesium level in SOC Cohort
|  | Low Mg (< 1.7 mg/dL) N = 12 | Normal Mg (1.7 – < 2.0 mg/dL) N = 30 | High Mg (≥ 2.0) N = 15 | Total N = 57 | P value |
|---|---|---|---|---|---|
Age | |||||
Median (Q1, Q3) | 61 (55, 65) | 57 (41, 62) | 60 (54, 64) | 59 (44–64) | 0.20 |
 Range | 38–75 | 27–77 | 27–77 | 27–77 |  |
Male sex | 6 (50%) | 18 (60%) | 10 (67%) | 34 (60%) | 0.67 |
Caucasian race | 8 (67%) | 26 (87%) | 13 (87%) | 47 (82%) | 0.33 |
Diagnosis | Â | Â | Â | Â | Â |
 DLBCL | 5 (42%) | 22 (73%) | 9 (60%) | 36 (63%) | 0.14 |
 HG | 4 (33%) | 2 (7%) | 1 (7%) | 7 (12%) |  |
 PMBCL | 0 (0%) | 0 (0%) | 1 (7%) | 1 (2%) |  |
 TFL | 3 (25%) | 6 (20%) | 4 (27%) | 13 (23%) |  |
ECOG PS ≥ 1 | 6 (50%) | 11 (37%) | 6 (40%) | 23 (40%) | 0.72 |
Elevated LDH (> 220 U/L), no (%) | 9 (75%) | 19 (63%) | 10 (67%) | 38 (67%) | 0.87 |
IPI ≥ 3, number (%) | 9 (75%) | 13 (43%) | 9 (60%) | 31 (54%) | 0.18 |
Stage III/IV Yes (%) | 12 (100%) | 27 (90%) | 15 (100%) | 54 (95%) | 0.41 |
Extranodal disease | 11 (92%) | 16 (53%) | 10 (67%) | 37 (65%) | 0.07 |
Prior lines of therapy | |||||
 Median (Q1, Q3) | 3.5 (3, 4) | 3 (3, 4) | 3.0 (2–4) | 3.0 (3, 4) | 0.25 |
 Range | 3–5 | 1–6 | 2–5 | 1–6 |  |
Prior ASCT | 6 (50%) | 14 (47%) | 5 (33%) | 25 (44%) | 0.68 |